Evidence map›Paper›PMID 26733886›Full record

ArticleFrontiers in physiology2015

TNFα-Damaged-HUVECs Microparticles Modify Endothelial Progenitor Cell Functional Activity.

Carlos Luna, Andrés Carmona, Matilde Alique, Julia Carracedo, Rafael Ramirez

Abstract read
In one paragraph

Article in Frontiers in physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carlos LunaInstituto Maimónides de Investigación Biomédica de Córdoba, Hospital Universitario Reina Sofía/Universidad de Córdoba, Cellular Damage in Chronic InflammationCórdoba, Spain; RETICs Red Renal (Instituto de Salud Carlos III)Madrid, Spain; Departamento Biología de Sistemas, Facultad de Medicina y Ciencias de la Salud, Universidad de AlcaláAlcalá de Henares, Spain.
Andrés CarmonaInstituto Maimónides de Investigación Biomédica de Córdoba, Hospital Universitario Reina Sofía/Universidad de Córdoba, Cellular Damage in Chronic InflammationCórdoba, Spain; RETICs Red Renal (Instituto de Salud Carlos III)Madrid, Spain.
Matilde AliqueDepartamento Biología de Sistemas, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá Alcalá de Henares, Spain.
Julia CarracedoInstituto Maimónides de Investigación Biomédica de Córdoba, Hospital Universitario Reina Sofía/Universidad de Córdoba, Cellular Damage in Chronic InflammationCórdoba, Spain; RETICs Red Renal (Instituto de Salud Carlos III)Madrid, Spain.
Rafael RamirezDepartamento Biología de Sistemas, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá Alcalá de Henares, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelial progenitor cells (EPCs) have an important role in the maintenance of vascular integrity and homeostasis. While there are many studies that explain EPCs mechanisms action, there are few studies that demonstrate how they interact with other emerging physiological elements such as Endothelial Microparticles (EMPs). EMPs are membranous structures with a size between 100 and 1000 nm that act as molecular information transporter in biological systems and are known as an important elements in develop different pathologies; moreover a lot of works explains that are novel biomarkers. To elucidate these interactions, we proposed an in vitro model of endothelial damage mediated by TNFalpha, in which damaged EMPs and EPCs are in contact to assess EPCs functional effects. We have observed that damaged EMPs can modulate several EPCs classic factors as colony forming units (CFUs), contribution to repair a physically damaged endothelium (wound healing), binding to mature endothelium, and co-adjuvants to the formation of new vessels in vitro (angiogenesis). All of these in a dose-dependent manner. Damaged EMPs at a concentration of 10(3) MPs/ml have an activating effect of these capabilities, while at concentrations of 10(5) MPs/ml these effects are attenuated or reduced. This in vitro model helps explain that in diseases where there is an imbalance between these two elements (EPCs and damaged EMPs), the key cellular elements in the regeneration and maintenance of vascular homeostasis (EPCs) are not fully functional, and could explain, at least in part, endothelial dysfunction associated in various pathologies.

Indexed as

angiogenesisendothelial microparticlesendothelial progenitor cellsHUVECsTNFalpha

Identifiers

PMID26733886
PMCPMC4686689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.